Jeffrey Stuart Peters - 22 Feb 2023 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role: Senior VP and General Counsel
Signature: /s/ Lynn Cilinski, Attorney-in-Fact
Issuer symbol: MGNX
Transactions as of: 22 Feb 2023
Net transactions value: -$22,126
Form type: 4
Filing time: 24 Feb 2023, 15:35:15 UTC
Previous filing: 17 Feb 2023
Next filing: 14 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MGNX	Common Stock	Options Exercise	$0	+8,750		$0.000000	8,750	22 Feb 2023	Direct	F1
transaction	MGNX	Common Stock	Tax liability	$22,126	-3,378	-39%	$6.55	5,372	22 Feb 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MGNX	Restricted Stock Unit	Options Exercise	$0	-8,750	-100%	$0.000000^*	0	22 Feb 2023	Common Stock	8,750	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 22, 2022 the reporting person was granted 35,000 restricted stock units, 25% of which vested on February 22, 2023 and 75% of which will vest two years after the date of grant. Restricted stock units convert into the Company's stock on a one-for-one basis.